2021/2022 HCPCS Code Q0180

Dolasetron mesylate, 100 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 24 hour dosage regimen
Short Description Dolasetron mesylate oral
HCPCS Coverage Code D = Special coverage instructions apply
HCPCS Action Code N = No maintenance for this code
HCPCS Action Effective Date April 01, 1998
HCPCS Code Added Date April 01, 1998
HCPCS Pricing Indicator Code 51 = Drugs
HCPCS Multiple Pricing Indicator Code A = Not applicable as HCPCS priced under one methodology
HCPCS Statute Number 4557
HCPCS Type Of Service Code 1 = Medical care
HCPCS Anesthesia Base Unit Quantity 0